Navigation Links
What is the effect of fluoxetine on mast cell?
Date:12/23/2008

Mast cells are now recognized as "granular cells of the connective tissue", whose activation exacerbates allergic immune responses and as key players in the establishment of innate immunity as well as modulators of adaptive immune responses. The role of mast cells in the gastrointestinal mucosa is not only to react to antigens, but also to actively regulate the barrier and transport properties of the intestinal epithelium. In clinical studies, it has become clear that psychological factors, especially anxiety and depression, play an important role in gastrointestinal diseases by precipitating exacerbation of symptoms. Fluoxetine hydrochloride (fluoxetine) is a kind of selective serotonin reuptake inhibitors (SSRIs), which belong to a class of antidepressants used in the treatment of depression and anxiety disorders.

The research team led by He-Shen Luo, from the Renmin Hospital of Wuhan University of China, investigated the effects of fluoxetine on mast cell morphology and rMCP-1 expression in gastric antrum in a rat model of depression. This will be published on December 7, 2008 in the World Journal of Gastroenterology.

A Sprague-Dawley rat model of chronic stress-induced depression was established. Fifty experimental rats were randomly divided into the five groups: normal control group, fluoxetine + normal control group, depressed model group, saline + depressed model group, and fluoxetine + depressed model group. Laser scanning confocal microscopy (LSCM) immunofluorecence and RT-PCR techniques were used to investigate rMCP-1 expression in gastric antrum. Mast cell morphology was observed under transmission electron microscopy.

They found that depression induced mast cell proliferation, activation, and granule hyperplasia. Compared with the normal control group, the average immunofluorescence intensity of gastric antrum rMCP-1 significantly increased in depressed model group (37.4 7.7 vs 24.5 5.6, P < 0.01) or saline + dep
'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
0086-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New study shows that a cough medicine ingredient could effectively treat prostate cancer
2. Common treatment for mens pelvic pain proves ineffective, Queens-led study shows
3. Experts Say Blood Sugar Guidelines Remain Effective
4. Cardiac stent patients with diabetes may benefit from drug that counteracts the effects of leptin
5. The Obama Effect: New Job Trends to Watch in 2009
6. MRI scans can predict effects of MS flare-ups on optic nerve
7. The profound effects of numbing agents
8. Precision Optics Corporation to Effect Reverse Split and Ticker Symbol Change
9. Treadmill Desks More Effective in Decreasing Prostate Cancer Risks Than Vitamin and Antioxidant Supplements
10. New Resource for No Side Effect Drugs
11. New therapy prevents dangerous side effect for lymphoma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 Dr. Francine Kaufman , inventor ... used with her patients in the 1980s: It weighed several pounds ... the most part, it could only be used in the hospital ... since then, and the advantages are greater as well. The insulin ... of the body, often on a belt or a pocket. It ...
(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 ... Care, ScripNet and Procura Management, today announced that ... Award at Catamaran’s client advisory meeting. Conferred ... has partnered with Catamaran to create cutting edge ... This year, Healthcare Solutions was recognized for its ...
(Date:5/21/2013)... Healthcare industry leaders, health information technology startups, and ... Emerging Healthcare Technology Conference, June 10 at the Fluno ... new event is part of the 11th annual Digital ... being held June 10-12 at the Fluno Center for ... for healthcare information technology (IT) grew dramatically in 2012 ...
(Date:5/21/2013)... 21, 2013 Two-thirds of patients who ... lung cancer reported that they engage in at least ... according to new findings from the National Health ... Health . The research will be presented today at ... for Pharmacoeconomics and Outcomes Research) in New Orleans. ...
(Date:5/21/2013)... May 21, 2013 The producers of ... air dates for Peterborough, Ontario, Canada. The area is famous ... for Canadians and Americans. It is located an hour from ... Peterborough is located in the Kawartha Hills, home to several ... economic stability to the area. Residents and visitors to this ...
Breaking Medicine News(10 mins):Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:“Start Me Up" Healthcare Conference: Where Healthcare CIOs, Entrepreneurs and Investors Meet 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3Health News:Net Worth Business TV Announces May Air Dates for Peterborough, Ontario 2
... Annual Dinner, May 17, DETROIT, Jan. 31 ... its nurse paging system, thanks to the,generosity of ... vice,president of development for the Institute., (Logo:, ... our 26th Annual Dinner May 17, Ford Motor ...
... Long-time local partners cite proprietary research, strategic planning and ... superior creative as keys to their success, ... two major,national advertising awards at the Consumer Health World Conference ... have again taken top honors in a national awards program., ...
... once looked at for cancer, also attacks the human immunodeficiency ... research published today online in the open access journal Retrovirology. ... learned to hide out in certain human cells where it ... serve as viral reservoirs. Operating from these havens, the virus ...
... ABAX ), a medical products company manufacturing point-of-care,blood analysis ... 31, 2007., Highlights for the third ... $25.7 million, up 17% over last year,s comparable quarter. ... over last year,s comparable quarter. ...
... Separate Research Confirms Part D Seniors Also Enjoy Broad ... Pharmaceutical Care,Management Association (PCMA) issued the following statement on ... drug benefit is lower over the,next ten years than ... saving money without sacrificing beneficiaries,choice of prescription drugs. New ...
... of its ongoing efforts to do whatever it takes ... for Parkinson,s disease, The Michael J. Fox Foundation for ... total funding to four industry teams seeking to push ... awards were granted under MJFF,s Therapeutics Development Initiative (TDI) ...
Cached Medicine News:Health News:Ford Motor Company Fund Continues Longtime Support to Cancer Care 2Health News:St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards 2Health News:St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards 3Health News:Anti-parasite drug may provide new way to attack HIV 2Health News:Anti-parasite drug may provide new way to attack HIV 3Health News:Anti-parasite drug may provide new way to attack HIV 4Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 2Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 3Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 4Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 5Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 6Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 7Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 8Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 9Health News:Michael J. Fox Foundation awards up to $3 million to industry teams 2Health News:Michael J. Fox Foundation awards up to $3 million to industry teams 3
(Date:5/21/2013)... Calif. , May 21, 2013 STAAR ... developer, manufacturer and marketer of minimally invasive ophthalmic products, ... investor conferences to review the Company,s recent financial results ... STAAR Surgical will present at the 38 th ... Boston at the Westin Waterfront Hotel ...
(Date:5/21/2013)... , May 21, 2013   RxAlly , ... nationwide, announces today the publication of a white ... Health Care System. The white paper highlights an ... and seeks public engagement to avert strains on ... Care refers to a range of individually-tailored, pharmacist-provided ...
(Date:5/20/2013)... , May 20, 2013  Volcano Corporation (NASDAQ: ... precision guided therapy tools designed to enhance the diagnosis ... announced it will highlight its efforts to expand research ... Flow Reserve (FFR) and iFR ® (Instant Wave-Free ... presentations and events at EuroPCR 2013 in ...
Breaking Medicine Technology:STAAR Surgical To Present At Upcoming Investor Conferences 2RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 2RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care 3Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4
... Study at the Annual Scientific Meeting of ... the American College of Rheumatology, ... cost-utility study supporting the adoption of EUFLEXXA(TM) (1%,sodium hyaluronate) intra-articular ... osteoarthritis (OA) of the knee at the American,College of Rheumatology,s ...
... Sustained and Dose-Dependent in Sub-Analysis of Phase II ... ... SCH 530348 (TRA), the,novel investigational antiplatelet agent in development by ... inhibitor of platelet,aggregation in a sub-analysis of the Thrombin Receptor Antagonist ...
Cached Medicine Technology:Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis 2Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis 3Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis 4SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 2SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 3SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 4SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 5SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 6SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 7
...
Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...
... product designed for LASIK surgery and other ... the corneal interface and/or stromal bed. Flattened ... and helps elevate the flap edge. Multiple ... G (.40 x 22mm). Angled 90 degrees, ...
... LASIK surgery and other types of ... corneal interface and/or stromal bed. Flattened ... flap and helps elevate the flap ... 23G x 7/8in (.60 x 22mm) ...
Medicine Products: